Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Lantern Pharma (LTRN) has issued an announcement.
On August 8, 2024, the Company is set to host a conference call and live webinar to discuss its second-quarter financial and operational results, as well as to present details regarding the LP-300 product candidate and its Harmonic™ Phase 2 clinical trial. These discussions aim to provide a comprehensive update to stakeholders and interested parties regarding the company’s recent performance and ongoing research developments.
Learn more about LTRN stock on TipRanks’ Stock Analysis page.
